Latest Bal Pharma stock price

Bal Pharma P/E Ratio

BALPHARMA • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
15.96
Moderate Valuation
Moderate - Fairly valued

Current Valuation Metrics

P/E Ratio 15.96
Current Price ₹72.44
EPS (TTM) ₹4.54
Exchange NSE

Valuation Signal

Signal Fairly Valued
Historical Avg 34.22
Historical Range 11.47 - 64.14
Percentile 25.0%

Sector Context

Sector Average 53.4
Sector Median 31.12
Sector Rank #11 of 132
Sector Percentile 8.3%

Earnings Breakdown (TTM)

TTM EPS ₹4.63
Sept 2025 ₹0.45
Mar 2025 ₹3.40

Key P/E Ratio Insights for Bal Pharma

  • Current PE is 53.4% below historical average
  • Trading at discount to sector average PE of 53.4

View the BALPHARMA equity price for detailed stock performance.

P/E Ratio Historical Trend for Bal Pharma

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2024 20.64 4.87 ₹100.50 NSE Moderate
2023 40.64 2.25 ₹91.45 NSE High
2022 64.14 1.98 ₹127.00 NSE High
2021 11.47 4.9 ₹56.20 NSE Low

Sector P/E Ratio Comparison

Comparing Bal Pharma with other companies in Healthcare sector
Sector Average
53.4
Sector Median
31.12
Lowest P/E
1.5
Highest P/E
628.04
Companies
132
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Welcure Drugs & Pharmace… WELCURE 1.5 ₹51 Low
Ind Swift Laboratories INDSWFTLAB 3.18 ₹733 Low
Murae Organisor MURAE 3.86 ₹55 Low
Fermenta Biotech FERMENTA 9.01 ₹1,010 Low
Zenith Drugs ZENITHDRUG 9.06 ₹84 Low
Galaxy Medicare GML 9.5 ₹32 Low
Balaxi Pharmaceuticals BALAXI 10.06 ₹139 Low
Natco Pharma NATCOPHARM 10.8 ₹17,006 Low
Vasundhara Rasayans VRL 11.3 ₹51 Low
Mohini Health & Hygiene MHHL 11.84 ₹69 Low